or Try an Advanced Search...

    Technical Analysis for KRBP - Kiromic BioPharma, Inc.

    Grade Last Price % Change Price Change
    F 3.11 0.97% 0.03
    KRBP closed up 0.97 percent on Friday, May 17, 2024, on 2.97 times normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or a pulls back.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Up Up
    Historical KRBP trend table...
    Date Alert Name Type % Chg
    Pocket Pivot Bullish Swing Setup 0.00%
    Bollinger Band Squeeze Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Stochastic Reached Overbought Strength 0.00%
    BB Squeeze + Upper Band Touch Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    Up 4 Days in a Row Strength 0.00%
    Older End-of-Day Signals for KRBP ...

       Recent Intraday Alerts

    Alert Time
    Possible Pocket Pivot 1 day ago
    Bullish 180 Entry 1 day ago
    Rose Above Previous Day's High 1 day ago
    2x Volume Pace 1 day ago
    1.5x Volume Pace 1 day ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    KRBP Chart by TradingView
    Basic chart:

    Profile

    Kiromic BioPharma, Inc. operates as a biotechnology company. The Company focuses on target discovery and gene editing through artificial intelligence and its proprietary neural network platform with a therapeutic focus on immuno-oncology. Kiromic BioPharma serves customers in the United States.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Artificial Intelligence Neural Network

    Is KRBP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 24 Kiromic BioPharma Reports Consistent Favorable Safety, Tolerability, and Efficacy in Deltacel-01 Clinical Trial First Three Patients
    Apr 10 Kiromic BioPharma files to withdraw registration statement
    Apr 2 Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial
    Mar 19 Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial
    Mar 8 Life Science Virtual Investor Forum Presentations Now Available for Online Viewing
    Mar 5 Life Science Virtual Investor Forum Agenda Announced for March 7th, 2024
    Mar 1 Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
    Feb 28 Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
    Feb 14 Results from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months
    Jan 29 Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung Cancer
    See more KRBP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 5.93
    52 Week Low 0.16
    Average Volume 3,947
    200-Day Moving Average 1.64
    50-Day Moving Average 2.59
    20-Day Moving Average 2.64
    10-Day Moving Average 2.68
    Average True Range 0.28
    RSI (14) 59.84
    ADX 16.5
    +DI 35.53
    -DI 21.10
    Chandelier Exit (Long, 3 ATRs) 2.30
    Chandelier Exit (Short, 3 ATRs) 3.08
    Upper Bollinger Bands 3.08
    Lower Bollinger Band 2.20
    Percent B (%b) 1.04
    BandWidth 33.12
    MACD Line 0.07
    MACD Signal Line 0.01
    MACD Histogram 0.0598
    Fundamentals Value
    Market Cap 3.91 Million
    Num Shares 1.26 Million
    EPS -19.51
    Price-to-Earnings (P/E) Ratio -0.16
    Price-to-Sales 0.00
    Price-to-Book 11.55
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.25
    Resistance 3 (R3) 3.23 3.17 3.22
    Resistance 2 (R2) 3.17 3.14 3.18 3.21
    Resistance 1 (R1) 3.14 3.11 3.16 3.16 3.21
    Pivot Point 3.08 3.08 3.09 3.09 3.08
    Support 1 (S1) 3.05 3.05 3.07 3.07 3.01
    Support 2 (S2) 2.99 3.02 3.00 3.01
    Support 3 (S3) 2.96 2.99 3.00
    Support 4 (S4) 2.98